Search all medical codes

Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, quantification

CPT4 code

Name of the Procedure:

Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, quantification Common name(s): HBV DNA Quantification, Hepatitis B Viral Load Test

Summary:

HBV DNA Quantification is a blood test used to measure the amount of hepatitis B virus (HBV) DNA in a patient's bloodstream. This test helps in assessing the activity and replication of the virus, providing important information about the infection's status.

Purpose:

The primary purpose of the procedure is to evaluate the severity of a hepatitis B infection. It helps in:

  • Monitoring the effectiveness of antiviral treatment
  • Making decisions about initiating or modifying therapy
  • Predicting disease progression

Indications:

The procedure is indicated for patients who:

  • Have been diagnosed with hepatitis B
  • Are undergoing antiviral therapy for hepatitis B
  • Show signs or symptoms of liver disease, such as jaundice, fatigue, and abdominal pain
  • Require liver transplant evaluation or monitoring

Preparation:

  • Typically, no special preparation is required.
  • Patients may be advised to continue their regular eating and medication routines unless instructed otherwise by their healthcare provider.
  • A prior consultation with a healthcare provider for a detailed medical history and accompanying liver function tests might be necessary.

Procedure Description:

  1. A healthcare professional will collect a blood sample, usually from a vein in the patient's arm.
  2. The sample is sent to a laboratory where it undergoes nucleic acid amplification techniques (e.g., PCR) to detect and measure the HBV DNA.
  3. If anesthesia is required for blood withdrawal anxiety, mild sedatives may be administered.

Duration:

The blood draw typically takes about 5–10 minutes. However, analysis and results can take several days to a week.

Setting:

The procedure is performed in various settings, such as:

  • Hospital laboratories
  • Outpatient clinics
  • Specialized diagnostic centers

Personnel:

  • Phlebotomist or nurse for blood draw
  • Laboratory technicians for sample analysis
  • Medical laboratory scientists for result interpretation

Risks and Complications:

  • Minor risks associated with blood draw, such as bruising, bleeding, or infection at the puncture site.
  • Rare risk of fainting during the blood draw.

Benefits:

  • Provides a precise measure of HBV activity in the body.
  • Helps tailor the treatment plan to individual patient needs.
  • Allows for timely adjustments in therapy for better disease management.

Recovery:

  • No recovery time is needed after the blood draw.
  • Patients can resume normal activities immediately.
  • Follow-up appointments may be scheduled based on test results.

Alternatives:

  • HBV serological tests (e.g., HBsAg, HBeAg, anti-HBc)
  • Liver function tests (ALT, AST levels)
  • Liver biopsy for direct liver tissue assessment
  • Alternatives vary in invasiveness, accuracy, and the type of information provided.

Patient Experience:

  • The patient will feel a small prick during the blood draw.
  • Some patients might experience minor discomfort or anxiety associated with the procedure.
  • Pain management typically includes topical anesthetic cream or reassuring conversation during the procedure.

Similar Codes